|
Federal
Register Notices > Manufacturers 2008
>
Cerilliant Corporation
FR Doc E8-24771[Federal Register: October 17, 2008 (Volume 73, Number 202)]
[Notices] [Page 61909-61911] From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr17oc08-136]
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances; Notice of Application
Pursuant to Sec.
1301.33(a) of Title 21 of the Code of Federal Regulations (CFR), this is
notice that on July 15, 2008, Cerilliant Corporation, 811 Paloma Drive, Suite A,
Round Rock, Texas 78665-2402, made application by renewal to the Drug
Enforcement Administration (DEA) as a bulk manufacturer of the basic classes of
[[Page 61910]]
controlled substances listed in schedules I and II:
|
Drug
|
Schedule
|
|
Cathinone (1235)
|
I
|
|
Methcathinone (1237)
|
I
|
|
N-Ethylamphetamine (1475)
|
I
|
|
N,N-Dimethylamphetamine (1480)
|
I
|
|
Aminorex (1585)
|
I
|
|
4-Methylaminorex (cis isomer) (1590)
|
I
|
|
Gamma-Hydroxybutyric acid (2010)
|
I
|
|
Methaqualone (2565)
|
I
|
|
Alpha-ethyltryptamine (7249)
|
I
|
|
Lysergic acid diethylamide (7315)
|
I
|
|
Marihuana (7360)
|
I
|
|
Tetrahydrocannabinols (7370)
|
I
|
|
Mescaline (7381)
|
I
|
|
3,4,5-Trimethoxyamphetamine (7390)
|
I
|
|
4-Bromo-2,5-dimethoxyamphetamine (7391)
|
I
|
|
4-Bromo-2,5-dimethoxyphenethylamine (7392)
|
I
|
|
4-Methyl-2,5-dimethoxyamphetamine (7395)
|
I
|
|
2,5-Dimethoxyamphetamine (7396)
|
I
|
|
2,5-Dimethoxy-4-ethylamphetamine (7399)
|
I
|
|
3,4-Methylenedioxyamphetamine (7400)
|
I
|
|
5-Methoxy-3,4-methylenedioxyamphetamine (7401)
|
I
|
|
N-Hydroxy-3,4-methylendioxyamphetamine (7402)
|
I
|
|
3,4-Methylendioxy-N-ethylamphetamine (7404)
|
I
|
|
3,4-Methylenedioxymethamphetamine (7405)
|
I
|
|
4-Methoxyamphetamine (7411)
|
I
|
|
Alpha-methyltryptamine (7432)
|
I
|
|
Bufotenine (7433)
|
I
|
|
Diethyltryptamine (7434)
|
I
|
|
Dimethyltryptamine (7435)
|
I
|
|
Psilocybin (7437)
|
I
|
|
Psilocyn (7438)
|
I
|
|
N-Benzylpiperazine (7493)
|
I
|
|
Acetyldihydrocodeine (9051)
|
I
|
|
Benzylmorphine (9052)
|
I
|
|
Codeine-N-oxide (9053)
|
I
|
|
Dihydromorphine (9145)
|
I
|
|
Heroin (9200)
|
I
|
|
Hydromorphinol (9301)
|
I
|
|
Methyldihydromorphine (9304)
|
I
|
|
Morphine-N-oxide (9307)
|
I
|
|
Normorphine (9313)
|
I
|
|
Pholcodine (9314)
|
I
|
|
Acetylmethadol (9601)
|
I
|
|
Allylprodine (9602)
|
I
|
|
Alphacetylmethadol except levo-alphacetylmethadol (9603)
|
I
|
|
Alphameprodine (9604)
|
I
|
|
Alphamethadol (9605)
|
I
|
|
Betacetylmethadol (9607)
|
I
|
|
Betameprodine (9608)
|
I
|
|
Betamethadol (9609)
|
I
|
|
Betaprodine (9611)
|
I
|
|
Hydroxypethidine (9627)
|
I
|
|
Noracymethadol (9633)
|
I
|
|
Norlevorphanol (9634)
|
I
|
|
Normethadone (9635)
|
I
|
|
Trimeperidine (9646)
|
I
|
|
Phenomorphan (9647)
|
I
|
|
Para-Fluorofentanyl (9812)
|
I
|
|
3-Methylfentanyl (9813)
|
I
|
|
Alpha-Methylfentanyl (9814)
|
I
|
|
Acetyl-alpha-methylfentanyl (9815)
|
I
|
|
Beta-hydroxyfentanyl (9830)
|
I
|
|
Beta-hydroxy-3-methylfentanyl (9831)
|
I
|
|
Alpha-Methylthiofentanyl (9832)
|
I
|
|
3-Methylthiofentanyl (9833)
|
I
|
|
Thiofentanyl (9835)
|
I
|
|
Amphetamine (1100)
|
II
|
|
Methamphetamine (1105)
|
II
|
|
Phenmetrazine (1631)
|
II
|
|
Methylphenidate (1724)
|
II
|
|
Amobarbital (2125)
|
II
|
|
Pentobarbital (2270)
|
II
|
|
Secobarbital (2315)
|
II
|
|
Glutethimide (2550)
|
II
|
|
Nabilone (7379)
|
II
|
|
1-Phenylcyclohexylamine (7460)
|
II
|
|
Phencyclidine (7471)
|
II
|
|
1-Piperidinocyclohexanecarbonitrile (8603)
|
II
|
|
Alphaprodine (9010)
|
II
|
|
Cocaine (9041)
|
II
|
|
Codeine (9050)
|
II
|
|
Dihydrocodeine (9120)
|
II
|
|
Oxycodone (9143)
|
II
|
|
Hydromorphone (9150)
|
II
|
|
Diphenoxylate (9170)
|
II
|
|
Benzoylecgonine (9180)
|
II
|
|
Ethylmorphine (9190)
|
II
|
|
Hydrocodone (9193)
|
II
|
|
Levomethorphan (9210)
|
II
|
|
Levorphanol (9220)
|
II
|
|
Isomethadone (9226)
|
II
|
|
Meperidine (9230)
|
II
|
|
Meperidine intermediate-A (9232)
|
II
|
|
Meperidine intermediate-B (9233)
|
II
|
|
Meperidine intermediate-C (9234)
|
II
|
|
Methadone (9250)
|
II
|
|
Methadone intermediate (9254)
|
II
|
|
Dextropropoxyphene, bulk (non-dosage forms) (9273)
|
II
|
|
Morphine (9300)
|
II
|
|
Thebaine (9333)
|
II
|
|
Levo-alphacetylmethadol (9648)
|
II
|
|
Oxymorphone (9652)
|
II
|
|
Noroxymorphone (9668)
|
II
|
|
Racemethorphan (9732)
|
II
|
|
Alfentanil (9737)
|
II
|
|
Sufentanil (9740)
|
II
|
|
Fentanyl (9801)
|
II
|
The company plans to manufacture small quantities of the listed controlled
substances to make reference standards which will be distributed to their
customers.
Any other such applicant, and any person who is presently registered with DEA
to manufacture such substances, may file comments or objections to the issuance
of the proposed registration pursuant to 21 CFR 1301.33(a).
Any such written comments or objections should be addressed, in quintuplicate,
to the Drug Enforcement Administration, Office of Diversion Control, Federal
Register Representative (ODL), 8701 Morrissette Drive, Springfield, Virginia
22152; and must be filed no later than December 16, 2008.
Dated: October 9, 2008.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. E8-24771 Filed 10-16-08; 8:45 am]
BILLING CODE 4410-09-P
NOTICE: This is an
unofficial version. An official version of these publications may be obtained
directly from the Government Printing Office (GPO).
|
